A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

Vanguard Study Site, Sherwood

Vanguard Study Site, Victoria Point

Vanguard Study Site, Morayfield

Vanguard Study Site, Brooklyn

Vanguard Study Site, Orlando

Vanguard Study Site, Lauderdale Lakes

Vanguard Study Site, Alabaster

Vanguard Study Site, Pelham

Vanguard Study Site, Hoover

Vanguard Study Site, Birmingham

Vanguard Study Site, Birmingham

Vanguard Study Site, Smyrna

Vanguard Study Site, Jackson

Vanguard Study Site, Columbus

Vanguard Study Site, Cincinnati

Vanguard Study Site, Dayton

Vanguard Study Site, Valparaiso

Vanguard Study Site, Rapid City

Vanguard Study Site, Missoula

Vanguard Study Site, St Louis

Vanguard Study Site, New Orleans

Vanguard Study Site, Hot Springs

Vanguard Study Site, Carrollton

Vanguard Study Site, Plano

Vanguard Study Site, Plano

Vanguard Study Site, Dallas

Vanguard Study Site, Dallas

Vanguard Study Site, Fort Worth

Vanguard Study Site, Houston

Vanguard Study Site, Pharr

Vanguard Study Site, Austin

Vanguard Study Site, St. George

Vanguard Study Site, Goodyear

Vanguard Study Site, Tolleson

Vanguard Study Site, Westminster

Vanguard Study Site, Anaheim

Vanguard Study Site, Medford

Vanguard Study Site, Ponce